CCMT
NVO

CMT Capital Markets Trading’s Novo Nordisk NVO Stock Holding History

CMT Capital Markets Trading’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-62,226
Closed -$2.95M – 408
2025
Q4 		$3.17M Buy
62,226
+2,937
+5% +$150K 0.03% 202
2025
Q3 		$3.29M Buy
59,289
+9,137
+18% +$535K 0.03% 203
2025
Q2 		$3.46M Buy
50,152
+7,706
+18% +$524K 0.04% 172
2025
Q1 		$2.95M Buy
+42,446
New +$3.51M 0.04% 171

Other funds holding NVO

Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
DAM
Diamant Asset Management Ridgefield, Connecticut $137B AUM 18.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return

CMT Capital Markets Trading's NVO Position: Q1 2026 in Review

CMT Capital Markets Trading sold out of Novo Nordisk (NVO) in Q1 2026, closing a stake of 62,226 shares — an estimated $2.95M sold.

CMT Capital Markets Trading first reported a position in NVO in Q1 2025 and held it in 4 quarters. The position peaked at $3.46M in Q2 2025. 1,270 funds tracked by Wall St. Rank hold NVO as of Q1 2026.

  • CMT Capital Markets Trading reported no remaining Novo Nordisk position as of Q1 2026 after selling out during the quarter.
  • CMT Capital Markets Trading sold 62,226 Novo Nordisk shares in Q1 2026, an estimated $2.95M.
  • CMT Capital Markets Trading first reported a position in Novo Nordisk in Q1 2025 and held it in 4 quarters.
  • CMT Capital Markets Trading's Novo Nordisk position peaked at $3.46M in Q2 2025.
  • 1,270 funds tracked by Wall St. Rank held Novo Nordisk as of Q1 2026.

Based on CMT Capital Markets Trading's 13F filing for Q1 2026, filed 15 May 2026.